The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
Adults (Age≥18)
Being HBsAg positive for at least six months
Being a citizen of the Republic of Türkiye
There are no exclusion criteria in this study.
To ensure that 20,000 patients with HBsAg positivity in Diyarbakir, Mardin, Batman and Sanliurfa are evaluated for HDV infection. To investigate HDV positive patients for liver fibrosis using the fibroscan method.
Other
Prospective
Anti Delta
Diagnostic testAnti Delta by ELISA
The frequency of HDV in certain regions of Southern Anatolia
The primary endpoint of this study is to determine the frequency of HDV in certain regions of Southern Anatolia, and the virological and liver fibrosis status of patients with HDV infection.
The rate of HIV and HCV co-infection in HDV positive patients
To determine the rate of HIV and HCV co-infection in HDV positive patients and to determine the demographic characteristics of HDV infected cases.
Click on the lead sponsor to view all of their trials.
Yaşar Bayındır, MD
Lead sponsor
Guven Health Group
Sponsor institution
SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY
Collaborator
Gilead Sciences
Collaborator
